Lab Information

Évelyne Vinet (MD/PhD)

Scientist
Centre for Outcomes Research and Evaluation
Department of Medicine (McGill)

Research Profile

 Fundamental: 0%
 Clinical: 10%
 Epidemiology: 90%
 Evaluation: 0%
 This email address is being protected from spambots. You need JavaScript enabled to view it.

Keywords

Systemic lupus erythematosus • rheumatoid arthritis • female reproductive health • epidemiology • pregnancy and rheumatic diseases • administrative databases • perinatal outcomes

Research Interests

The primary goal of my research program is to use epidemiologic methods to improve reproductive health outcomes in women with rheumatic diseases, such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), and their offspring. To this end, I have created the world's largest cohort of offspring from SLE women, which has driven our novel findings demonstrating that SLE offspring are at increased risk of autism spectrum disorders, congenital heart defects, and stillbirths. I am also actively spear-heading research initiatives to elucidate how therapies used to treat rheumatic diseases (e.g. TNF-inhibitors and other biologics) impact health outcomes in these patients and their offspring.

Research areas: Clinical Epidemiology; Rheumatic Diseases; Non-Communicable Disease Epidemiology; Pharmacoepidemiology; Population and Public Health


Team Members

Name Position

Latest Publications

  1. Mainbourg, S., Sheehy, O., Gorgui, J., Vinet, E. & Bérard, A. (2024). Trends in medications for autoimmune disorders during pregnancy and factors for their discontinuation: a population-based study. BMC pregnancy and childbirth, vol. 24, p. 765.
  2. Mendel, A. & Vinet, É. (2024). Connecting the Docs in Vasculitis Pregnancies. The Journal of rheumatology, vol. 51, p. 949-952.
  3. Mendel, A., Behlouli, H., Vinet, É., Curtis, J. R. & Bernatsky, S. (2024). Trimethoprim sulfamethoxazole prophylaxis and serious infections in granulomatosis with polyangiitis treated with rituximab. Rheumatology (Oxford, England).
  4. Flatman, L. K., Malhamé, I., Colmegna, I., Bérard, A., Bernatsky, S. & Vinet, É. (2024). Tumour necrosis factor inhibitors and serious infections in reproductive-age women and their offspring: a narrative review. Scandinavian journal of rheumatology, p. 1-12.
  5. Schreiber, K., Giles, I., Costedoat-Chalumeau, N., Nelson-Piercy, C., Dolhain, R. J., Mosca, M., Förger, F., Fischer-Betz, R., Molto, A., Tincani, A., Pasquier, E., Marin, B., Elefant, E., Salmon, J., Bermas, B. L., Sammaritano, L., Clowse, M. E. B., Chambers, C., Buyon, J., Inoue, S. A., Agmon-Levin, N., Aguilera, S., Emadi, S. A., Andersen, J., Andrade, D., Antovic, A., Arnaud, L., Christiansen, A. A., Avcin, T., Badreh-Wirström, S., Bertsias, G., Bini, I., Bobirca, A., Branch, W., Brucato, A., Bultink, I., Capela, S., Cecchi, I., Cervera, R., Chighizola, C., Cobilinschi, C., Cuadrado, M. J., Dey, D., Etomi, O., Espinosa, G., Flint, J., Fonseca, J.-E., Fritsch-Stork, R., Gerosa, M., Glintborg, B., Skorpen, C. G., Goulden, B., Graversgaard, C., Gunnarsson, I., Gupta, L., Hetland, M., Hodson, K., Hunt, B. J., Isenberg, D., Jacobsen, S., Khamashta, M., Levy, R., Linde, L., Lykke, J., Meissner, Y., Moore, L., Morand, E., Navarra, S., Opris-Belinski, D., Østensen, M., Ozawa, H., Perez-Garcia, L. F., Petri, M., Pons-Estel, G. J., Radin, M., Raio, L., Rottenstreich, A., Ruiz-Irastorza, G., Tunjić, S. R., Rygg, M., Sciascia, S., Strangfeld, A., Svenungsson, E., Tektonidou, M., Troldborg, A., Vinet, E., Vojinovic, J., Voss, A., Wallenius, M. & Andreoli, L. (2023). Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases. The Lancet. Rheumatology, vol. 5, p. e501-e506.
  6. Smith, N. A. & Vinet, É. (2024). Ambulatory Fetal Heart Monitoring: the New Kid on the Block?. Arthritis & rheumatology (Hoboken, N.J.), vol. 76, p. 345-347.
  7. Sacre, K., Vinet, E., Pineau, C. A., Mendel, A., Kalache, F., Grenier, L.-P., Huynh, T. & Bernatsky, S. (2024). N-Terminal pro-Brain Natriuretic Peptide is a biomarker for cardiovascular damage in systemic lupus erythematous: a cross-sectional study. Rheumatology (Oxford, England), vol. 63, p. 1739-1745.
  8. Mendel, A., Behlouli, H., de Moura, C. S., Vinet, É., Curtis, J. R. & Bernatsky, S. (2023). Trimethoprim-sulfamethoxazole prophylaxis during treatment of granulomatosis with polyangiitis with rituximab in the United States of America: a retrospective cohort study. Arthritis research & therapy, vol. 25, p. 133.
  9. Gorodensky, J. H., Bernatsky, S., Afif, W., St-Pierre, Y., Filion, K. B. & Vinet, É. (2023). Assessing Serious Infections in Children Exposed In Utero to Ustekinumab. The Journal of rheumatology.
  10. Lee, J.-E., Mendel, A., Askanase, A., Bae, S.-C., Buyon, J. P., Clarke, A. E., Costedoat-Chalumeau, N., Fortin, P. R., Gladman, D. D., Ramsey-Goldman, R., Hanly, J. G., Inanç, M., Isenberg, D. A., Mak, A., Mosca, M., Petri, M., Rahman, A., Sanchez-Guerrero, J., Urowitz, M., Wallace, D. J., Bernatsky, S. & Vinet, É. (2023). Systemic Lupus Erythematosus Women with Lupus Nephritis in Pregnancy Therapeutic Challenge (SWITCH): The Systemic Lupus International Collaborating Clinics experience. Annals of the rheumatic diseases, vol. 82, p. 1496-1497.
More on PubMed 



See also

Card image
Sasha
Bernatsky


See profile
Card image
Christian
Pineau


See profile
Card image
Arielle
Mendel


See profile
Card image
Waqqas
Afif


See profile
Card image
Inés
Colmegna


See profile
Card image
Emily
McDonald


See profile